BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Ebola outbreak
Hantavirus
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Thursday, June 4, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
May 7, 2018
View Archived Issues
MenoGeniX receives grant from NIA for drug to treat menopausal hot flashes
Read More
FDA grants fast track designation for PaxVax's chikungunya VLP vaccine
Read More
GAL-200-10 controls corneal neovascularization and fibrosis in vivo
Read More
DSMB gives another recommendation for phase III FOCUS trial
Read More
Astellas reports pipeline highlights of fourth quarter of fiscal 2017
Read More
Novel oral antibiotic DDS-01 presented for treating multidrug-resistant gonorrhoea infections
Read More
Cancer therapy driven by dopamine D2 receptor antagonism shows promise
Read More
Merck & Co. patents novel LXR-beta agonists
Read More
FDA approves Tafinlar with Mekinist for BRAF-positive anaplastic thyroid cancer
Read More
Isofol receives FDA feedback on SPA for pivotal study of arfolitixorin in colorectal cancer
Read More
Sage Therapeutics identifies GluN2A and/or GluN2B NAMs
Read More
Evolve doses first pediatric patient in phase III trial of PlasmaCap IG
Read More
FDA grants priority review to Tecentriq sBLA for first-line treatment of metastatic NSCLC
Read More
Lilly initiates phase III study of mirikizumab in moderate to severe plaque psoriasis
Read More
monARC Bionetworks begins strategic integration with Roivant drug development platform
Read More
Novel ELOVL4 gene mutation tied to spinocerebellar ataxia with retinitis pigmentosa
Read More
Charles River Laboratories extends collaboration with Michael J. Fox Foundation
Read More
ORR data from KEYNOTE-407 trial of Keytruda in first-line NSCLC support sBLA submission
Read More
New mutation in SLC20A2 gene found in Fahr's disease
Read More
FDA approves IND for female hair loss trial of Histogen's HSC-660
Read More
